Melatonin Increases Bone Mass around the Prostheses of OVX Rats by Ameliorating Mitochondrial Oxidative Stress via the SIRT3/SOD2 Signaling Pathway
Open Access
- 11 April 2019
- journal article
- research article
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2019, 1-16
Abstract
Bone mass loss around prostheses is a major cause of implant failure, especially in postmenopausal osteoporosis patients. In osteoporosis, excess oxidative stress largely contributed abnormal bone remodeling. Melatonin, which is synthesized from the pineal gland, promotes osteoblast differentiation and bone formation and has effectively been used to combat oxidative stress. Thus, we determined if melatonin can inhibit oxidative stress to promote osteogenesis and improve bone mass around prostheses in osteoporosis. In this study, we observed that received melatonin at 50 mg/kg body weight significantly increased periprosthetic bone mass as well as implant fixation intensity in ovariectomized (OVX) rats. Meanwhile, it decreased the expression of oxidative stress markers (NAPDH oxidase 2 and cytochrome c) and enhanced expressing level of the formation markers of bones (alkaline phosphatase, osteocalcin, and osterix) around prostheses compared to that in the control group. Additionally, melatonin decreased hydrogen peroxide- (H2O2-) induced oxidative stress and restored the osteogenesis potential of MC3T3-E1 cells. Mechanistically, melatonin clearly increased mitochondrial sirtuin 3 (SIRT3) expression and decreased the ratio of acetylated superoxide dismutase 2 (AC-SOD2)/SOD2 compared to the H2O2group. SIRT3 inhibition counteracted the protective effects of melatonin on oxidative stress and bone formation. Together, the results showed that melatonin ameliorated oxidative stress in mitochondrial via the SIRT3/SOD2 signaling pathway, thereby promoting osteogenesis, improving bone mass around the prostheses, and increasing initial stability. Thus, melatonin might be a suitable candidate to decrease the rate of implant failure and lengthen the lifespan of prostheses after total joint arthroplasty.Keywords
Funding Information
- National Natural Science Foundation of China (81372018, 81472077, 81672238, 81873991, 81873990, QNRC2016751, BK20180001)
- National Natural Science Foundation of China (81372018, 81472077, 81672238, 81873991, 81873990, QNRC2016751, BK20180001)
- National Natural Science Foundation of China (81372018, 81472077, 81672238, 81873991, 81873990, QNRC2016751, BK20180001)
- National Natural Science Foundation of China (81372018, 81472077, 81672238, 81873991, 81873990, QNRC2016751, BK20180001)
- National Natural Science Foundation of China (81372018, 81472077, 81672238, 81873991, 81873990, QNRC2016751, BK20180001)
- Jiangsu Provincial Medical Youth Talent (81372018, 81472077, 81672238, 81873991, 81873990, QNRC2016751, BK20180001)
- Natural Science Foundation of Jiangsu Province (81372018, 81472077, 81672238, 81873991, 81873990, QNRC2016751, BK20180001)
This publication has 60 references indexed in Scilit:
- Calorie Restriction and SIRT3 Trigger Global Reprogramming of the Mitochondrial Protein AcetylomeMolecular Cell, 2013
- Bisphosphonate Therapy for Osteoporosis: Benefits, Risks, and Drug HolidayThe American Journal of Medicine, 2013
- Low BMD affects initial stability and delays stem osseointegration in cementless total hip arthroplasty in womenActa Orthopaedica, 2012
- Sirt3-Mediated Deacetylation of Evolutionarily Conserved Lysine 122 Regulates MnSOD Activity in Response to StressMolecular Cell, 2010
- Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safetyBMC Medicine, 2010
- Oxidative stress in bone remodelling and diseaseTrends in Molecular Medicine, 2009
- Denosumab for Prevention of Fractures in Postmenopausal Women with OsteoporosisNew England Journal of Medicine, 2009
- Projections of Primary and Revision Hip and Knee Arthroplasty in the United States from 2005 to 2030Journal of Bone and Joint Surgery, 2007
- Estrogen deficiency and bone loss: an inflammatory taleJournal of Clinical Investigation, 2006
- Safety and Adverse Effects Associated With Raloxifene: Multiple Outcomes of Raloxifene EvaluationObstetrics & Gynecology, 2004